Palliative anti-cancer treatment
Palliative anti-cancer treatment directly treats the cancer when the main aim is not cure. It may be intended to:
- shrink or control the cancer;
- slow its growth;
- relieve or prevent symptoms;
- help someone live longer;
- preserve quality of life.
It can include chemotherapy, immunotherapy, targeted treatment, hormone treatment, radiotherapy, surgery or another procedure. It is active treatment, but its benefit has to be weighed against side effects and treatment burden.
Symptom control and supportive care
Supportive care prevents or treats symptoms and the effects of cancer or its treatment. It can include pain relief, anti-sickness medicines, blood transfusions, nutritional support, treatment of infection, physiotherapy and psychological support.
It should be available during curative or palliative treatment. Supportive care is not reserved for the final stage of illness, and it does not require anti-cancer treatment to stop.
Specialist palliative care
Specialist palliative care teams have particular expertise in complex symptoms, psychological and social support, communication, and planning care around a person's priorities.
They can be involved early and at the same time as cancer treatment. A referral does not by itself mean that death is imminent. It means the team believes additional expertise could help with symptoms, support or decision-making.
End-of-life care
End-of-life care supports people who are approaching the end of life. Its focus is comfort, dignity, priorities and support for the patient and those close to them.
It can involve specialist palliative care, community teams, hospices, GPs and hospital services. This is not a synonym for all palliative care, and it is not a synonym for all palliative anti-cancer treatment.
The four concepts can overlap. A person may receive palliative chemotherapy and specialist palliative care together. Another may receive curative treatment and specialist symptom support. Someone receiving end-of-life care may no longer be having anti-cancer treatment, but their medical and personal care continues.
How doctors judge whether palliative anti-cancer treatment is worthwhile
The team considers:
- the chance of cancer control or symptom improvement;
- how quickly benefit might occur;
- possible side effects and recovery time;
- other health conditions and performance status;
- previous treatment;
- the person's priorities and daily life.
The balance can change. Treatment may continue while it is helping and side effects remain manageable. It may be adjusted, paused or stopped if it is no longer providing enough benefit. What happens if cancer treatment stops working? explains the next-step discussion.
Why the language varies
You may hear disease control, life-prolonging treatment, symptom-directed treatment, best supportive care or treatment with palliative intent. These phrases overlap but are not always interchangeable.
Ask what the proposed treatment is intended to do in your situation. The precise aim matters more than the label.
Questions to ask
- Is this anti-cancer treatment, supportive care or both?
- What is the treatment intended to achieve?
- How likely is it to help, and how will we know?
- What side effects and time commitments are most relevant?
- Can specialist palliative care help alongside treatment?
- What care would I receive if I did not have this anti-cancer treatment?
Receiving palliative anti-cancer treatment does not necessarily mean that death is imminent. It means the treatment has a non-curative aim, and its value should be judged by the benefit it can realistically offer the individual person.
